Kinled Holding

Xapien is a developer of an artificial intelligence-based online research platform focused on third-party risk management. The company leverages advanced technologies such as artificial intelligence and natural language processing to automate the research process, providing on-demand insights about individuals and companies worldwide. By enhancing clients' internal research capabilities, Xapien delivers comprehensive and context-rich information that aids in informed decision-making. This innovative approach not only streamlines research efforts but also reduces costs associated with internal and outsourced research, giving clients a competitive edge in managing risks effectively.

Connect Earth, founded in 2021 and based in London, is an environmental data company focused on providing accessible sustainability information. The company specializes in carbon tracking API technology, which allows users to understand the environmental impact of their daily spending. By standardizing carbon emissions data and calculating carbon footprints, Connect Earth empowers individuals and businesses to make informed, sustainable choices. Its API toolkit integrates sustainability insights into financial products, enabling financial institutions to offer customers transparent views of their climate impact. Through this approach, Connect Earth aims to bridge the gap between intent, knowledge, and action, fostering a culture of sustainable finance.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions. Founded in 2016 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that automates various aspects of privacy program management, including privacy impact assessments, data inventory mapping, and risk remediation actions. OneTrust’s solutions facilitate compliance with global regulations by providing tools for vendor risk management, incident reporting, and website compliance, as well as managing data subject rights and consent. The platform serves a diverse clientele ranging from multinational corporations to small and medium enterprises, allowing them to collaborate effectively on privacy risks associated with customer, employee, and vendor data. OneTrust also provides training and certification programs, ensuring that organizations can maintain continuous compliance through ongoing audits and assessments. With additional offices worldwide, OneTrust is positioned to support businesses in navigating the complexities of privacy regulations across various sectors and jurisdictions.

Nanoflex Robotics, founded in 2021, is a MedTech startup focused on advancing treatment options for vascular diseases, particularly acute ischemic strokes. The company is developing a proprietary telerobotic platform that enables remote mechanical thrombectomy, a procedure that allows healthcare professionals to perform crucial interventions from a distance. This innovative technology utilizes precise electromagnetic fields to navigate magnetic devices through complex vascular anatomy, facilitating faster and more effective patient care. By improving access to timely treatments, Nanoflex Robotics aims to enhance patient outcomes, increase hospital profitability, and promote health equity. The company's advancements have garnered positive feedback from notable clinical partners, including the Jacobs Institute, Mayo Clinic, and Toronto Health, underscoring the potential impact of its solutions in the medical field.

Hi.health is a company focused on transforming the claims process in private health insurance by addressing inefficiencies and enhancing user experience. It offers a health insurance application that integrates secure payment methods with a range of digital services, including invoice and prescription management. By providing co-branded debit cards to insurers' members, Hi.health eliminates out-of-pocket expenses, allowing users to access health-related facilities globally. The platform delivers real-time data, reducing claims lag and operational costs while minimizing fraud. Additionally, it implements a rewards program to encourage cost-effective behavior among users. Ultimately, Hi.health aims to significantly improve the user experience for insurance members while helping insurers achieve substantial cost savings.

Algonist Biotechnologies is a pre-clinical stage biotechnology company focused on developing innovative small molecule therapeutics aimed at treating chronic and neuropathic pain. The company specializes in creating non-opioid drugs that offer improved efficacy compared to existing treatment options, while minimizing the serious side effects commonly associated with current pain medications. By concentrating on oral small-molecule therapeutics, Algonist Biotechnologies seeks to provide patients with effective and rapid relief from chronic pain without causing harm to neurons in the peripheral and central nervous systems.

Cebina Bridge Capital is a venture capital investment firm established in 2021 and based in Gibraltar. The company specializes in investing in pharmaceutical drug discovery and biotechnology projects, with a particular emphasis on opportunities in Central and Eastern Europe. By targeting these sectors, Cebina Bridge Capital aims to support innovative developments that can contribute to advancements in healthcare and medicine.

Five Lives is a London-based digital therapeutics company focused on enhancing brain health through its innovative mobile application, Sharp. The platform is designed to assist users in measuring and managing their cognitive health, ultimately aiming to reduce the risk of cognitive decline. By providing an engaging and user-friendly tool, Five Lives empowers individuals to adopt healthier lifestyles, thereby improving their overall well-being and extending their quality of life. This proactive approach aims to facilitate earlier detection of dementia and promote long-term cognitive health for users.

Master your emotions in 5 minutes a day. Ahead is a personalized pocket coach that provides bite-sized, science-driven tools to boost emotional intelligence. Think of it as a pocket cheerleader towards a better, more fulfilling, clearer-minded way of life. Most of us continuously set goals for our life - for our career, our relationships, our health. Yet, it’s damn hard to turn those goals into reality! We know - we’ve been there ourselves. That’s why we know there’s a way to make it work. And that’s what aHead is all about! Get early access: ahead-app.com

PreComb is a biotechnology company focused on enhancing cancer therapy by developing innovative technologies that tailor treatments to individual patients, particularly for challenging cancers. The company specializes in automated microtumor-based profiling, which allows clinical institutions to conduct in vitro cancer diagnostics directly at the hospital. This technology enables the functional evaluation of various cancer drugs, combinations, and concentrations on patient-derived micro-tumors, thereby optimizing treatment outcomes. By improving the precision of cancer management, PreComb aims to increase success rates in therapies and ultimately enhance the quality of life for patients battling cancer.

Tridek-One is a biotechnology company focused on developing immunomodulatory products aimed at addressing auto-immune and inflammatory disorders. The company's primary product is a peptide designed to maintain a cluster of truncated CD31 molecules at the membrane, which helps moderate overactive immune responses without complete blockade. By facilitating improved treatment options for medical companies, Tridek-One seeks to enhance the quality of life for patients suffering from these conditions.

OctaiPipe is a technology company specializing in Federated Learning Operations (FL-Ops) architecture designed for Edge AIoT devices. The company provides a comprehensive platform that simplifies the entire lifecycle of developing and deploying distributed AIoT solutions. This includes effortless setup, training, deployment, fine-tuning, and continuous learning, enabling data scientists to create systems that can learn and adapt at scale. By leveraging OctaiPipe's solutions, organizations can enhance critical infrastructure with improved efficiency, sustainability, resilience, and security, all while reducing the costs associated with monitoring, maintenance, upgrades, and auditing.

Accelus specializes in developing medical implants aimed at enhancing minimally invasive spine surgery. The company focuses on expandable interbody technology, offering a bi-directional expandable cage that combines the strength and rigidity of a traditional monolithic implant. This innovative design allows healthcare professionals to effectively address various spinal issues, including height, weight, and lordosis problems. Accelus is dedicated to improving access to its advanced surgical solutions, particularly in markets that have been historically underserved.

Adsum is a London-based fintech company established in 2020, focusing on providing instant value-added tax refunds and tax credits for UK businesses. The company has developed a software infrastructure that facilitates immediate VAT refunds through embedded software integrations with partner organizations. Utilizing artificial intelligence and machine learning, Adsum simplifies the tax credit process, helping businesses reduce human error and enhance growth. By specializing in R&D and Creative Industry Tax Credits, Adsum aims to deliver value-added services that support the financial needs of its clients.

BVNK is a fintech company specializing in modern payments infrastructure for businesses. It unifies traditional banking systems with blockchain technology on a single platform, enabling businesses to send and receive stablecoin payments, convert currencies, and add crypto payment options to their checkout processes. BVNK's flexible platform allows innovators to swiftly launch new payment products while ensuring compliance through its robust global licensing expertise.

Engimmune Therapeutics is a biotechnology company focused on developing innovative T cell receptor (TCR) therapies aimed at treating solid tumors. The company leverages advanced life sciences technologies, including genome editing, functional high-throughput screening, deep sequencing, and machine learning, to create highly potent and specific immunotherapies. By addressing critical efficacy and safety challenges in cancer treatment, Engimmune Therapeutics is dedicated to providing effective solutions for patients suffering from serious diseases with significant unmet medical needs.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Wiredirect is a global financial technology and FX liquidity firm that has built a whole new way to make payments across borders.

CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects.

Opal is a digital control application focused on helping users manage their screen time effectively. Designed to improve productivity and mental well-being, Opal provides features that restrict distracting applications and track time saved. With over 200,000 users, including teams from startups and Fortune 500 companies, Opal aims to assist individuals in reclaiming their time and enhancing their focus. The application combines real-time feedback and rewards to encourage better daily habits, aligning with its mission to help one billion people focus more effectively and achieve their personal and professional goals.

Lapse is a social disposable camera application that allows users to capture and share photos in a nostalgic format reminiscent of traditional disposable cameras. The app facilitates private group chats where users can take up to 36 snapshots, creating a "roll" that is only accessible to group members for a limited time after the first image is taken. This design encourages spontaneity and a sense of shared experience among friends, promoting an engaging way to document moments together while maintaining privacy.

Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision oncology therapeutics. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond positively to specific treatments, thereby enhancing the effectiveness of its drug development efforts. Acrivon's pipeline features its lead program, ACR-368 (prexasertib), which is currently in Phase 2 trials, alongside several preclinical programs targeting key components of DNA damage response and cell cycle regulation, including WEE1 and PKMYT1. By concentrating on complex oncology drug targets that are often not addressed by traditional therapies, Acrivon aims to expedite the advancement of both in-licensed clinical-stage assets and its internally developed programs through accelerated registration trials.

Cobee is a Madrid-based company founded in 2018 that develops an online platform aimed at automating and simplifying employee benefits management. The platform provides a centralized solution for companies to manage employee benefits, enabling them to offer flexible compensation options without the need for intermediaries. Employees receive a VISA card linked to the platform, allowing them to pay for various expenses such as meals, transportation, daycare, training, and medical insurance. Cobee's application provides real-time visibility into expenditures and savings, enhancing user experience and fostering satisfaction among both companies and employees. By streamlining the benefits process and consolidating information, Cobee improves service quality and reduces costs associated with employee benefits management.

Fernride is a developer of an advanced autonomous driving platform tailored for fleet operators, specializing in yard trucking solutions that enhance productivity, sustainability, and worker safety. The company's innovative approach integrates teleoperations with autonomous driving technology, allowing for remote control of trucks when needed. This human-assisted autonomy ensures reliable and efficient logistics operations. Founded by Hendrik Kramer, Maximilian Fisser, and Jean-Michael Georg, Fernride has amassed over a decade of research and significant clientele, including prominent companies such as Volkswagen, HHLA, and DB Schenker. With a dedicated team of over 150 employees, Fernride addresses major challenges in the logistics sector, including driver shortages and environmental concerns, by introducing scalable automation solutions for yard trucking.

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, specializing in the development of innovative therapies for advanced liver diseases and cancers associated with Claudin-1 (CLDN1) expression. Founded in 2019, Alentis focuses on addressing conditions such as liver fibrosis, cirrhosis, and liver cancer through the use of anti-CLDN1 antibody-drug conjugates and other targeted treatments. The company's unique approach combines clinically relevant read-outs with advanced techniques like single-cell RNA sequencing of patient liver tissues, aiming to reverse disease progression and improve patient outcomes. Alentis Therapeutics is recognized for its pioneering role in exploring anti-CLDN1 therapeutics, contributing to advancements in the treatment of fibrotic diseases and CLDN1-positive tumors.

Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.

Sylvera is a carbon data provider based in London, United Kingdom, established in 2020. The company specializes in developing machine learning-based tools to monitor the performance of carbon offset projects. These tools enable remote tracking of project performance at intervals of up to a week, facilitating the integration of carbon data into both internal and external reporting frameworks. By offering enhanced transparency around carbon offsets, Sylvera aims to assist businesses and governments in reducing reputational risks associated with carbon emissions, ultimately promoting real-world climate action.

Receeve is a developer of a customizable online platform designed for collections and recovery. This cloud-native, no-code solution simplifies the complexities of data and systems, enabling in-house teams to automate processes, engage customers, and utilize comprehensive insights to optimize recovery and mitigate risk throughout the credit management lifecycle. The platform supports various stages, from pre-delinquency to portfolio assignment or sale, offering a blend of ease-of-use and powerful functionality. By integrating intelligence, strategy, and operations into a single platform, receeve enhances operational effectiveness and transparency for businesses, financial institutions, and funds of all sizes.

PreComb is a biotechnology company focused on enhancing cancer therapy by developing innovative technologies that tailor treatments to individual patients, particularly for challenging cancers. The company specializes in automated microtumor-based profiling, which allows clinical institutions to conduct in vitro cancer diagnostics directly at the hospital. This technology enables the functional evaluation of various cancer drugs, combinations, and concentrations on patient-derived micro-tumors, thereby optimizing treatment outcomes. By improving the precision of cancer management, PreComb aims to increase success rates in therapies and ultimately enhance the quality of life for patients battling cancer.

Gitpod is an open-source platform that automates the provisioning of ready-to-code development environments, streamlining the workflow for engineering teams. By alleviating the burdens of manual setup, Gitpod saves developers significant time and enhances collaboration, allowing them to focus on coding rather than environment configuration. The platform is natively integrated with popular version control systems such as GitLab, GitHub, and Bitbucket, enabling automatic and continuous prebuilding of development environments for all branches. This empowers team members to begin coding immediately with fresh environments tailored for various tasks, whether they are developing new features, resolving bugs, or conducting code reviews. Overall, Gitpod transforms the development process by providing prebuilt workspaces that facilitate efficiency and productivity.

Bob W is a provider of short-stay accommodation services that offers an alternative to traditional hotels. The company operates a managed marketplace of serviced apartments that combine the quality standards and amenities of a lifestyle hotel with the authenticity and functionality of a home. Each apartment is locally designed, work-friendly, and equipped with hotel linens and professional cleaning services. Additionally, the accommodations feature fully equipped kitchens, access to local gyms, and curated breakfast options. This approach allows travelers to easily find and enjoy short-stay accommodations tailored to their needs while ensuring a high standard of service and ecological mindfulness.

Eirion Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of advanced prescription products for aesthetic dermatology. The company's product pipeline includes treatments aimed at addressing various conditions such as wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion is committed to meeting significant unmet clinical needs within the field, with plans to explore additional indications in the future. Through its innovative approach, Eirion Therapeutics aims to provide effective solutions for both physicians and patients dealing with aesthetic concerns.

Muse Finance is a technology platform designed to facilitate working capital solutions for B2B businesses. By integrating seamlessly with client operations, it provides end-to-end financing options that enhance user engagement and overall client experience. The platform offers a no-code and API integration, allowing businesses to implement white-label financial services rapidly. Muse Finance's offerings include three primary products: trade finance, buy now pay later for businesses, and invoice finance tailored for UK limited companies. Additionally, the platform features a real-time dashboard for businesses to manage client funding requests and monitor progress, alongside tools for cash flow forecasting and risk management. Ultimately, Muse Finance enables small businesses to optimize their financial operations and make informed decisions based on accurate credit insights and instant credit assessments.

Cofenster is a company that specializes in video production automation through its innovative suite of Video AI assistants. These assistants work independently or collaboratively with teams in communication, HR, and marketing to enhance video creation efficiency while maintaining human creativity. Cofenster’s offerings include Milo, which generates viral short clips from longer videos; Ella, which creates authentic user-generated content; and Theo, which converts text into engaging videos. Additionally, the company has developed a mobile application that allows users to produce professional-quality corporate videos directly from their smartphones. This application streamlines the entire video production process, encompassing planning, recording, post-production, and the addition of elements such as subtitles, music, and corporate branding. Cofenster serves a diverse clientele, including prominent corporations like TUI, Rewe Group, Siemens, Beiersdorf, and Vorwerk, as well as small and medium-sized enterprises.

Herophilus is a biotechnology company focused on developing innovative neurotherapeutics aimed at treating brain disorders. The company utilizes advanced techniques, including human brain models, scaled biology, and machine learning, to systematically identify and develop novel drugs with therapeutic potential. By employing phenotypic screening, Herophilus aims to discover new treatments for complex neurological and psychiatric conditions such as epilepsy, autism, and schizophrenia. Their mission is to enable healthcare professionals to offer effective treatments for patients suffering from these disorders, ultimately assisting individuals in managing the emotional and cognitive symptoms associated with neurological issues.

HomeHero is a digital home management platform designed to simplify household tasks for users. It offers a comprehensive solution that consolidates utility bill management, household chores, and home repairs into a single, user-friendly system. By utilizing cloud-based architecture and integrating mobile and IoT technologies, HomeHero allows users to manage all their household services efficiently. The platform enables users to report maintenance issues, schedule cleaning services, and even handle administrative tasks such as receiving packages or coordinating with contractors. With a focus on convenience and cost-effectiveness, HomeHero provides access to online experts ready to assist through live chat, ensuring that all household needs are met seamlessly.

Primer API Limited operates an online platform that consolidates fragmented payment ecosystems for e-commerce merchants and online payment facilitators. Founded in 2019 and based in London, the company provides solutions to optimize both front and backend payment flows, aiming to enhance authorization rates, minimize costs, and facilitate market expansion. Primer enables users to seamlessly connect with various third-party services, including payment service providers, fraud detection systems, and subscription billing engines. Its platform allows merchants to easily integrate new payment methods, streamline fraud mitigation, and implement sophisticated transaction routing without requiring coding skills. Through these capabilities, Primer enhances the overall commerce experience for customers and empowers businesses to improve their operational efficiency.

Greyparrot is an innovator in AI waste analytics, focused on enhancing recycling efficiency and reducing waste sent to landfills and incinerators. The company offers a waste intelligence platform that includes the Greyparrot Analyzer and Greyparrot Sync API, which provide real-time insights into over 89 waste categories across multiple data layers, such as financial value, brand, and greenhouse gas emissions. In 2024, Greyparrot analyzed over 40 billion waste objects, significantly improving operational efficiency and driving substantial cost savings for recycling facilities. By leveraging its advanced software, which employs intelligent waste recognition and low-cost hardware, Greyparrot enables clients in the waste sector—including recycling professionals, plant builders, and packaging producers—to make informed decisions that enhance recycling rates and comply with regulations. The company has received numerous accolades, including recognition as a Global Cleantech 100, a World Economic Forum Tech Pioneer, and a top AI company by CB Insights.

Corlieve Therapeutics SAS is a biotechnology company based in Paris, France, dedicated to developing innovative therapeutic options for patients suffering from severe neurological disorders. Founded in 2019, the company focuses on a lead project that targets aberrantly expressed kainate receptors in the hippocampus of patients with temporal lobe epilepsy (TLE) through a gene therapy approach. This novel AAV gene therapy program aims to address refractory TLE, leveraging scientific research from notable institutions such as INSERM, CNRS, Aix Marseille University, and the University of Bordeaux. By advancing its therapeutic strategies, Corlieve Therapeutics seeks to enhance the quality of life for individuals impacted by these challenging conditions.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering chemotherapeutic agents directly to targeted antibodies. This innovative platform allows for the rapid production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, enabling the use of readily available antibodies. The site-specific conjugation process facilitates swift manufacturing and reliable quality control, supporting the creation of safe and potent drugs for various diseases. Araris Biotech's technology is protected by two patents, underscoring its commitment to advancing cancer treatment through improved safety and tolerability for patients.

NativeWaves is a technology company that specializes in audio synchronization and streaming solutions aimed at enhancing live event viewing experiences. By collaborating with partners, the company identifies compelling content and develops tools that allow for personalized and synchronized delivery of multimedia content across multiple screens. NativeWaves' software effectively translates movies, sports events, and videos into various languages without causing interruptions or synchronization delays. Additionally, it provides real-time statistics and insights on alternate screens, enabling viewers to engage with their favorite events in preferred languages and formats. The company's commitment to delivering intuitive and user-friendly technology ensures that existing workflows remain unchanged while enhancing the overall experience for audiences worldwide.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

doctorly GmbH is a health technology company based in Berlin, Germany, specializing in a cloud-based practice management platform for healthcare professionals. Founded in 2017, the company offers a comprehensive software-as-a-service solution that streamlines various aspects of medical practice management. Its platform enables digital booking, video conferencing, and the management of electronic health records, enhancing efficiency for doctors while improving patient engagement. Additionally, doctorly provides tools for patient health analysis and integrates with other health industry applications, facilitating seamless connections between healthcare providers and patients. By focusing on innovative digital solutions, doctorly aims to drive meaningful improvements in the healthcare sector on an international scale.

Agro.Club is a full-stack B2B global marketplace focused on the agricultural sector, operating primarily in Europe, South America, and North America. The company aims to enhance the efficiency and sustainability of the food supply chain by leveraging technology to connect various stakeholders in the agriculture value chain. With a user base exceeding 40,000 farmers and thousands of grain companies, Agro.Club employs advanced analytics and algorithms to ensure transparency in the market and to rapidly match supply with demand. Its custom-built platform facilitates the entire transaction process, including quality control, KYC compliance, logistics, and financing, making it a unique player in the global grain marketplace. Agro.Club is already operationally profitable, reflecting its effective approach to addressing the complexities of the agricultural supply chain.

Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, specializing in virtual reality-based psychotherapy solutions for anxiety disorders. Established in 2017, the company develops medical applications aimed at enhancing mental health through innovative technologies. Sympatient offers two primary products: Otemi, which provides users with tasks and exercises to manage stress and promote relaxation, and Invirto, an anxiety therapy application that delivers therapeutic information and strategies, allowing patients to address their anxiety disorders independently from home. Additionally, Sympatient provides a CE-certified medical device for individuals diagnosed with anxiety disorders. By integrating technology with therapeutic practices, the company aims to make mental health treatment more accessible and personalized.

Accure Therapeutics S.L. is a pharmaceutical company based in Barcelona, Spain, focused on the development, production, and marketing of drugs aimed at treating central nervous system (CNS) diseases. As a clinical-stage research and development entity, Accure Therapeutics specializes in creating disease-modifying therapies for both severe orphan and non-orphan CNS disorders. The company is committed to accelerating the transition to effective treatments for disabling brain conditions, thereby enabling healthcare professionals to better address the complexities of CNS-related illnesses.

Schüttflix GmbH is a digital marketplace and delivery platform based in Gütersloh, Germany, specializing in the delivery of bulk construction materials such as sand, crushed rock, and gravel. Founded in 2018, the company serves as a logistics hub for the construction industry, connecting construction companies, building material suppliers, waste disposal firms, and freight forwarders through its application. The platform facilitates the ordering, tracking, and management of construction materials, allowing users to streamline their operations, reduce downtime, and enhance project efficiency.

Planetly is a Berlin-based software company specializing in intelligent carbon management. It provides a platform that automates the process from data collection to reduction strategies and offsetting measures, helping businesses gain transparency into their carbon footprint and take pragmatic action against climate change. Planetly serves various sectors including banking, insurance, manufacturing, retail, and IT, assisting them in analyzing, reducing, and offsetting their organizational carbon footprints.

CALYXHA Biotechnologies GmbH is a biotechnology company based in Vienna, Austria, established in 2019. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary factor in various significant human diseases. Through its research and development efforts, CALYXHA seeks to create solutions that could potentially transform treatment options for patients suffering from conditions linked to tissue degeneration.

Superscript is a digital insurance broker catering to businesses of all sizes, from startups to established enterprises. The company operates a self-serve online platform that allows small and medium-sized businesses to buy and manage their insurance quickly, often within minutes. As the first UK-based InsurTech to become a Lloyd’s of London broker, Superscript specializes in providing tailored coverage for innovative companies facing complex risks. Utilizing a price comparison tool and a flexible monthly subscription model, Superscript simplifies the insurance process, enabling users to generate quotes, set up coverage, and make adjustments or cancellations with ease.

Coindirect is a cryptocurrency trading platform focused on accelerating adoption across Africa and other emerging markets. Founded by a team from South Africa, it offers an end-to-end solution that allows users to buy and sell various cryptocurrencies directly on a peer-to-peer marketplace with 0% transaction fees. Users can engage in transactions using multiple payment methods, including credit cards, local bank transfers, and PayPal. Coindirect supports over 40 cryptocurrencies and altcoins, including ERC-20 tokens, and provides 15 trading pairs on its exchange platform. The service caters to a wide range of users, from first-time buyers to experienced investors, enabling them to securely manage their assets in one place. Additionally, Coindirect offers access to its underlying technology via an API for other fintech services. By bridging the gap between traditional finance and the cryptocurrency landscape, Coindirect aims to facilitate mainstream adoption of digital currencies.

Motorpharma is a biotechnology company focused on developing drug candidates that target motor proteins, specifically to address spasticity in patients. The company provides drug development services that facilitate research and enhance treatment options for healthcare professionals. Its innovative myosin inhibitors are designed to alleviate the symptoms of spasticity, particularly in individuals recovering from strokes. By improving the accessibility and effectiveness of these treatments, Motorpharma aims to support healthcare providers in delivering better care to their patients.

Motley London Ltd, established in 2017 and headquartered in London, specializes in designing, manufacturing, and retailing jewelry. The company offers a wide range of products including earrings, necklaces, rings, bracelets, and charms, all sold exclusively online. Motley London collaborates with renowned jewelry designers from around the world to create its collections, aiming to provide customers with unique, high-quality pieces.

Black Insurance is an innovative insurance platform that leverages blockchain technology to streamline the insurance industry. By connecting local managing general agents (MGAs), brokers, and agents directly with capital, Black removes traditional insurance companies from the value chain. This model allows local agents to design, price, and sell insurance products tailored to their markets while handling claims efficiently. The use of blockchain not only minimizes expenses and delays associated with conventional insurance processes but also enhances scalability by decentralizing business decisions, bringing them closer to the end customers. Black Insurance aims to transform the insurance landscape by offering a more agile and responsive alternative to traditional methods.

Intercontinental Capital is a premier cross-border financial advisory firm.

DRUID AI is a company specializing in an end-to-end AI platform designed for enterprise use. Founded in 2018, the company focuses on enabling rapid development and deployment of AI agents, knowledge bases, and intelligent applications to automate business processes and enhance technology return on investment. DRUID AI's solutions facilitate personalized, secure interactions across multiple channels while integrating seamlessly with existing business systems and robotic process automation technologies. The platform leverages proprietary Natural Language Processing technology to interpret user intent, providing contextually relevant information based on behavior and preferences. This empowers developers to create natural and rich interactions between employees, customers, partners, and enterprise systems through text and voice conversations across various channels. DRUID AI has established a network of over 200 partners and serves more than 300 clients globally.

Aleva Neurotherapeutics SA is a Swiss company specializing in the development of advanced implantable deep brain stimulation (DBS) systems. Founded in 2008 and based in Lausanne, Aleva focuses on creating next-generation neurostimulation devices that utilize microelectromechanical systems (MEMS) technology. Its flagship product, directSTIM, features an array of directional microelectrodes that enable precise electrical stimulation, enhancing the efficacy of DBS therapy for conditions such as Parkinson's disease and essential tremor. In addition, Aleva has developed spiderSTIM, a diagnostic system that maps three-dimensional brain targets to optimize stimulation, and cortiSTIM, designed for cortical stimulation. The company is committed to maximizing the potential of its technology by launching a series of therapeutic products while carefully managing development risks. Aleva Neurotherapeutics is ISO13485 certified, underscoring its dedication to quality and safety in the medical device sector.

ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.

Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.

Yonder AG is a Swiss company based in Zurich, founded in 2015, that specializes in documentation-as-a-service (DaaS) solutions. The company's flagship offering, Yonder Mind, is an application designed for efficient information management, enabling organizations to create, maintain, and deliver information effectively to users. Yonder AG focuses on streamlining the documentation process by providing shorter, more relevant documents and manageable revisions, alongside services for document content creation and conversion. Through its innovative solutions, Yonder AG aims to enhance the way businesses handle their information needs.

Orchestra BioMed is a biomedical innovation company based in New Hope, Pennsylvania, founded in 2017. The company specializes in developing high-impact therapeutic solutions for major medical conditions, with a primary focus on cardiovascular diseases, which are responsible for approximately 31% of global deaths annually. Orchestra BioMed's business model involves strategic partnerships with medical device companies to accelerate the commercialization of its products. Its key product candidates include BackBeat Cardiac Neuromodulation Therapy for hypertension and Virtue Sirolimus AngioInfusionBalloon for atherosclerotic artery disease.

NovaGo Therapeutics AG is a biotechnology company based in Schlieren, Switzerland, focused on researching and developing human antibody therapeutics aimed at treating cerebral stroke and spinal cord injury. Founded in 2015, the company specializes in recombinant human monoclonal antibodies that target the nerve outgrowth inhibitor Nogo-A, with the goal of stimulating nerve repair and regeneration. NovaGo Therapeutics has established a strategic partnership with Neurimmune Holding AG, which allows access to a unique class of human-derived antibodies with promising therapeutic properties derived from their Reverse Translational Medicine™ technology platform. Through its innovative approach, NovaGo Therapeutics seeks to advance treatment options for patients suffering from neurological injuries.

Sonect is a financial technology company that offers a platform enabling local businesses to function as virtual ATMs, allowing customers to withdraw and deposit cash using their smartphones. By connecting individuals seeking cash with nearby shops willing to facilitate transactions, Sonect reduces the costs associated with traditional ATM operations. This innovative approach not only benefits consumers by providing convenient, fee-free access to cash at local establishments but also helps shops attract new customers and earn commissions. Additionally, banks can leverage Sonect's services to lower ATM operating costs and expand their presence in new markets without significant capital investment. Overall, Sonect fosters community engagement and enhances the cash distribution process, benefiting all parties involved.

Doctify Limited is a HealthTech company that operates an online platform enabling patients to search, compare, and book appointments with healthcare specialists across various medical fields, including cardiology, dermatology, and orthopedics, among others. Founded in 2014 and headquartered in London, the platform allows users to filter their options based on verified patient reviews, distance, and availability, ensuring they find the most suitable healthcare provider for their needs. In addition to serving patients, Doctify offers tools for healthcare professionals to manage their practices, enhance patient engagement, collect feedback, and reduce appointment no-shows through automated reminders. The company has expanded into five markets and continues to pursue aggressive growth plans, focusing on improving the overall patient experience by leveraging real-time insights from patient feedback.

Mytos is a company focused on creating a fully automated cell manufacturing platform tailored for the biotechnology sector, particularly in drug development. The platform utilizes advanced automation technology to streamline the production of human cells, allowing pharmaceutical and biotech companies to optimize their cell culture processes. By enabling scientists to easily modify culturing protocols, Mytos facilitates more rapid advancements in cell growth and overall efficiency in research and development. This innovative approach aims to enhance the capabilities of businesses in the drug development industry by providing a sophisticated solution for cell production.

medHF performs Human Factors research at Formative and Validation stages of medical device / combination product development.

BaseLaunch is a venture builder firm located in Basel, Switzerland, focused on launching and developing startups across various therapeutic sectors, including oncology, immunology, and cardiovascular health. The program spans 15 months and is divided into two phases, providing non-dilutive funding and access to a network of leading healthcare partners. Participants benefit from the expertise of seasoned advisors and state-of-the-art infrastructure, while being integrated into Basel's vibrant biotech ecosystem. BaseLaunch is supported by prominent industry leaders such as Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche, and Roivant Sciences, along with various public and private collaborators.

YoFumo Technologies Inc. is a Denver, Colorado-based company that specializes in manufacturing innovative solutions for the cannabis industry. Established in 2015, it focuses on post-harvest processing and storage technologies, offering products such as Yofumo Pro+, a comprehensive solution for curing, aging, and managing cannabis after trimming, and the Quad System, which addresses post-harvest processing needs. Additionally, YoFumo Pro provides environmental control and monitoring capabilities for cannabis handling. The company's patent-pending technology enables effective decontamination and curation, allowing for antimicrobial treatment and terpene management without the use of harmful chemicals, thereby enhancing product consistency and quality.

In a constantly changing society, speed and assertiveness speak louder. Pocket devices help us to make decisions and save us time in choosing the right ones. We're constant updated about our favorite shows, favorite artists, fancy restaurants. The time has come for this to be replicated to our favorite neighborhood, our favorite city, our dream home/property. In an increasingly technological market, we believe in using artificial intelligence to provide an intelligent connection between SELLER and SEEKERS. Thinking this way, CASAFY brings to the market a POWERFUL App, which offers a fast and intelligent connection between both. The right properties for the right customer, at the right time in their lives. All this easily and accessible at the touch of a finger. This puts the real estate market once and for all in the 21st century, meaning no paperwork, making life easier for those who sell, those who intermediate and those who buy. Thus, we can offer a new proposal reaching from A-Z, from the low cost to the high luxury customer. Imagine seeing only what you want, without needing filters or wasting months searching for the ideal property. We do it for you, without you realizing it, because we have a clean interface with no advertisements. We aim to go where the eyes can't, using imagination and innovation to transform the reality of the entire real estate chain, from the construction company, through the intermediation of real estate and brokers, to the person who acquires the property . Casafy is online in Brazil, with over 1.2 million real estate sale and rental offers published!

Spiral Therapeutics, Inc. is a clinical-stage pharmaceutical company founded in 2016 and based in San Francisco, California. The company specializes in developing novel therapies for inner ear disorders, particularly focusing on acute and subacute hearing loss as well as balance disorders caused by neurodegenerative, inflammatory, or vascular issues. Spiral Therapeutics employs a unique platform that aims to deliver targeted drug therapies directly to the inner ear, optimizing treatment effectiveness by ensuring that the right medications are administered at the right location and for the appropriate duration. Through its innovative approach, the company seeks to provide patients with effective treatments for hearing loss and related conditions.

CheckYeti GmbH is an online platform and mobile application that facilitates the booking of ski instructors, ski schools, and mountain guides across various outdoor activities. Founded in 2014 and based in Vienna, Austria, CheckYeti offers users access to over 12,000 activity options in more than 1,000 mountain and beach destinations throughout Europe. The platform allows users to compare different instructors and guides based on reviews and pricing, enabling them to choose their preferred options. Additionally, it provides instructors and guides with enhanced visibility and the ability to interact directly with customers, as well as receive individual feedback. This comprehensive service caters to both winter and summer activities, including skiing, snowboarding, rafting, paragliding, and more, making it a valuable resource for holidaymakers and outdoor enthusiasts.

Rebio Technologies Limited, established in 2014 and based in Cranleigh, UK, is a biomedical company specializing in the development and manufacturing of bioresorbable polymers for medical devices and pharmaceuticals. It formulates and supplies multiple grades of these materials, catering to both medical device and active drug programs. Rebio's unique selling proposition lies in its proprietary polymer technology, which enables the efficient and cost-effective production of high-value chemicals through fermentation, addressing safety and efficacy challenges in sustained release approaches. The company's offerings include active drug programs and active medical device programs, with a focus on renewable resources and innovative solutions for manufacturing industries.

Public is a venture capital firm based in London, United Kingdom, focused on supporting technology startups that aim to enhance public services. Established in 2016, Public operates as an accelerator, providing capital, networks, insights, and support to help these startups thrive. One of its key initiatives is GovStart, a six-month growth program designed to cultivate a new pipeline of technology firms dedicated to transforming the public sector. Through this program and its broader support framework, Public seeks to foster innovation and improve the effectiveness of public services in the UK.

System1 Biosciences, Inc. is a San Francisco-based neurotherapeutics company established in 2017, specializing in drug discovery for complex neurological and psychiatric disorders, including epilepsy, autism, and schizophrenia. The company employs phenotypic screening, integrating cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to uncover novel characterizations of diseases. This innovative approach allows System1 to identify "deep phenotypes," which are utilized to discover new therapeutic targets and drug treatments, addressing gaps in traditional discovery techniques that have struggled with these challenging conditions.

Veesion is a technology company specializing in gesture recognition for real-time detection of shoplifting within the retail sector. Founded in 2018 and based in Paris, France, Veesion utilizes deep learning algorithms to analyze footage from security cameras, identifying gestures indicative of theft. The system autonomously generates alerts that are sent to human operators for confirmation and subsequent action. This innovative software can be integrated with existing surveillance systems, allowing retailers and distributors to enhance their security measures while optimizing the allocation of security personnel. By providing an ethical and effective solution to combat shoplifting, Veesion is reshaping the standards of retail security.

GotCourts Ltd is a software as a service (SaaS) platform based in Zurich, Switzerland, that specializes in the online community for racquet sports enthusiasts. Established in 2014, GotCourts provides tools for players, coaches, and court operators, facilitating the booking of courts and coaching services. The platform allows users to find playing partners, track their progress, and stay connected with fellow racquet sport participants. By aiming to become a comprehensive hub for tennis and other racquet sports, GotCourts enhances the experience for sports lovers, streamlining processes and unlocking the potential of the racquet sports community.

Lava Therapeutics B.V. is a biotechnology company based in Utrecht, the Netherlands, focused on innovative cancer treatments. Founded in 2016, it specializes in the development of proprietary bispecific antibodies that engage gamma-delta T cells, aiming to harness the immune system's power to target and destroy tumor cells. The company's platform creates next-generation γδ T cell engaging antibodies designed for both hematological and solid tumors, emphasizing safety, potency, and cost-effectiveness in its biopharmaceuticals. By combining immune recruiting and activating functionalities, Lava Therapeutics seeks to transform cancer therapy and improve patient outcomes.

Wagz, Inc. is a pet technology company based in Portsmouth, New Hampshire, specializing in smart collars for dogs. Founded in 2015, the company offers the Wagz Collar, which combines GPS tracking, health monitoring, and location enforcement to keep dogs safe and connected with their owners. The collar features an activity monitor that tracks health and behavior, an LED light for visibility, and a high-definition live streaming camera that can be activated remotely or by bark detection. Additionally, Wagz provides the Wagz Serve Smart Feeder, which ensures dogs receive the proper nutrition at designated times, and mobile applications that allow users to manage collar settings, record medical data, and engage with a community of fellow dog owners. Wagz products are available through various resellers in the United States and online, catering to the needs of modern pet owners.

Houst, formerly known as Airsorted, is a short-term rental management service based in London, U.K. Founded in 2015, the company specializes in providing a comprehensive platform for homeowners looking to maximize their rental income while minimizing the complexities associated with short-let hosting. Houst manages various aspects of property letting, including listing creation, pricing optimization, marketing, and guest management. By automating these processes, the company aims to deliver a hassle-free experience for homeowners, allowing them to achieve higher rental yields without the stress of day-to-day operations. With a mission to simplify home-sharing, Houst caters to both individual homeowners and the broader market by promoting efficient and effective rental practices.

NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address critical health challenges by researching and scaling solutions for conditions that often remain untreated. Notably, NRx has announced the commercialization of ZYESAMI (Aviptadil), which targets COVID-related respiratory failure. Additionally, the company is advancing NRX-100/101, a pioneering sequential drug regimen designed for the treatment of bipolar depression in patients experiencing acute suicidal ideation and behavior. In a significant development, NRx was granted exclusive worldwide rights to develop and market the BriLife COVID vaccine by the Government of Israel, further expanding its portfolio in the fight against serious health threats.

Heist Studios Limited is a London-based company that specializes in manufacturing tights for women. Founded in 2015, the brand aims to redefine bodywear by innovating the traditional tight. Heist Studios operates primarily through online sales, rapidly gaining popularity and achieving significant sales milestones, including over 100,000 pairs sold within its first year of operation. The company has experienced substantial growth, with a monthly increase of 25% in sales. It has garnered notable recognition in the fashion industry, with endorsements from prominent publications such as Vogue and STYLE magazine, which praised its quality and innovation in the luxury tights market.

UV Light Care, Inc. is a medtech company based in Boston, Massachusetts, that focuses on the development and application of ultraviolet (UV) light technology for disinfection and other medical purposes. Incorporated in 2015, the company has specialized in creating disinfection solutions aimed particularly at vascular access devices and indwelling catheters, addressing critical needs within the medical community. Through its innovative technology, UV Light Care aims to enhance patient safety and improve infection control practices in healthcare settings.

Triple Dragon is a financial services provider specializing in facilitating the growth of game and application developers, as well as publishers, through user acquisition loans. The company offers a range of flexible investment products designed to fund marketing campaigns and user acquisition efforts, allowing clients to expand their install base and boost revenue without relinquishing equity. By supporting the financing needs of gaming technology stakeholders, Triple Dragon helps its clients launch and scale their projects effectively, contributing to their overall business growth.

Vertus Capital provides capital to help facilitate the sale and purchase of advice firms.

Loma is a company that operates a search portal designed to connect consumers with options for secondhand renting and repair services. By aggregating information about various resale websites, Loma facilitates access to secondhand goods, promoting sustainability and resource reuse. The company also leverages advanced resale pricing prediction technology, which accurately tracks and forecasts the resale value of products down to specific model numbers. This innovation addresses the significant issue of mispricing in the resale market, potentially saving resellers billions in lost revenue while making the resale industry more efficient and profitable. Through its platform, Loma aims to make secondhand shopping more accessible and appealing, benefiting both consumers and businesses in the growing resale market.

DF Capital specializes in building relationships with manufacturers and offering working capital solutions throughout supply chains. By providing flexible finance products, DF Capital assists businesses in driving their growth and aligning their cash cycle with lending terms. This approach allows companies to effectively manage cash flow and meet their financial needs for continued expansion and success.

AdaptHealth is a provider of patient-centered healthcare-at-home solutions, specializing in home medical equipment (HME), medical supplies, and associated services. The company distributes a wide range of clinically driven products designed to support patients in living independently, including sleep and respiratory therapy equipment, mobility aids, wound care supplies, and nutrition services. AdaptHealth also offers vital services such as continuous glucose monitoring and insulin pumps for diabetes management, as well as oxygen and chronic therapy services. Founded in 2012 and headquartered in Phoenixville, Pennsylvania, the company serves patients and healthcare institutions across several states, including Pennsylvania, New Jersey, New York, Maryland, and Delaware. Additionally, AdaptHealth provides online bill payment services to assist patients in managing their medical equipment expenses.

omicX is a company based in Le Petit Quevilly, France, that operates a bioinformatics platform designed to facilitate access to biotechnology tools. Established in 2012, omicX aims to harness the growing collective intelligence in bioinformatics to leverage biological Big Data for various applications across biotechnology, life sciences, medicine, agriculture, and industry. Its primary offering, OMICtools, serves as a valuable resource for scientists and developers, providing information on tools for storing, processing, and sharing significant volumes of biological data. The platform also enables users to engage with the scientific community by posting questions, sharing expertise, and providing feedback on available tools. This innovative approach has positioned omicX as a trusted leader and global reference in the bioinformatics field, attracting users from prestigious universities, medical institutions, pharmaceutical companies, and the biotech industry.

Bricksave is a global real estate investment platform that facilitates access to property investments around the world. It offers a curated selection of unique properties in prime locations such as Miami, London, and Paris, enabling both first-time and experienced investors to participate with a minimum investment of $1,000. The platform is designed to streamline the investment process, allowing users to manage their investments quickly and efficiently, without the need for human interaction. Investors can benefit from rental income and potential capital gains from property sales, while Bricksave handles the ongoing management of the properties. This approach allows investors to diversify their portfolios and achieve competitive, secure returns with minimal effort.

Frontier Car Group is a Berlin-based startup focused on developing and operating used automotive marketplaces in emerging markets, including Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. The company aims to simplify the process of buying and selling used cars through its online platform, which features a digital quote engine that provides instant pricing for vehicles. This technology not only enhances the efficiency of transactions but also facilitates quick vehicle inspections at designated locations. By leveraging innovative business models and infrastructure, Frontier Car Group is able to create value for all stakeholders involved in the used car market. Additionally, the company is engaged in joint ventures with OLX in India and Poland, further expanding its reach and impact in the automotive sector.

Mavencare Inc. is a home care service provider based in Toronto, Canada, with additional locations in Calgary, Ottawa, and Edmonton. The company is dedicated to helping seniors age in place by offering a comprehensive range of services, including companionship, meal preparation, personal care, respite care, and specialized nursing services. Mavencare's approach integrates technology to streamline caregiver vetting and hiring, ensuring that clients are matched with suitable caregivers. The use of proprietary mobile technology also facilitates communication among families, caregivers, and healthcare professionals, while machine learning tools help identify potential health risks for patients. Founded by individuals who faced challenges in securing quality care for their grandparents, Mavencare strives to revolutionize home health care and enable seniors to live comfortably in their own homes, addressing the needs of the millions of older adults in North America who wish to remain in familiar surroundings as they age.

PlayStack is a game publishing company dedicated to supporting developers in realizing their creative visions. Established on the belief that talented developers often need assistance, PlayStack offers a range of services to facilitate their success. These include comprehensive funding, expert publishing guidance, and technological support aimed at building strong gaming audiences and communities. Drawing on years of experience in leading, producing, and publishing successful games, PlayStack provides the necessary resources and knowledge to help developers effectively navigate the journey from concept to global recognition. Through its commitment to fostering innovative games, PlayStack enables creators to approach their projects with confidence and strategic direction.

Homeshift builds a simple online dashboard that lets users see their existing services. They design homes and services from scratch. They provide services in internet, energy, water, and council.

Iproteos is a biotechnology company specializing in the research and development of innovative therapeutic strategies aimed at modulating protein-ligand and protein-protein interactions through the use of peptidomimetics. The company employs its proprietary IPRO technology platform to discover and develop therapeutic agents targeting diseases of the central nervous system, including schizophrenia, epilepsy, and pediatric cancer. Iproteos focuses on third-generation drugs that leverage advanced understanding of protein interactions to create effective treatments. With expertise in peptidomimetics, Iproteos positions itself as a valuable partner for organizations seeking to advance their own therapeutic targets in the biomedical field.

KB Medical SA is a Swiss company that specializes in the design, development, and commercialization of robotic assistance systems for the healthcare industry, particularly in spinal surgery. Founded in 2012 and based in Lausanne, Switzerland, the company is known for its AQrate robotic system, which assists surgeons during spinal fusion procedures. The technology behind the AQrate system enhances surgical precision, reduces radiation exposure for operating room teams, and aims to improve patient outcomes and quality of life following surgery. KB Medical is certified under ISO 13485 for the design and manufacture of its robotic systems, highlighting its commitment to high-quality medical devices. As of 2017, KB Medical operates as a subsidiary of Globus Medical, Inc.

Pockit Limited is a fintech company based in London, United Kingdom, that offers financial services primarily to individuals who are often excluded or underserved by traditional banks. Established in 2010, Pockit provides a prepaid MasterCard along with an online account that enables customers to receive their wages and benefits directly. Users can fund their accounts through various methods, including debit cards and bank transfers, at multiple locations across the UK. The company also offers a mobile application for both iPhone and Android devices, allowing customers to manage their finances conveniently. Pockit's services extend to in-store, online, and international usability, as well as cashback savings solutions, making it a comprehensive option for those seeking accessible banking alternatives.

3Derm Systems, Inc., based in Boston, Massachusetts, is a pioneering company in 3D dermatology that provides a specialized handheld skin imager and cloud-based software designed for capturing, storing, and transmitting high-resolution 3D images of the skin. Established in 2011, the company enables non-dermatologists to take clinical-quality skin images remotely, facilitating efficient monitoring of skin lesions by dermatologists. This innovative approach reduces healthcare costs, shortens wait times, and enhances access to dermatological care, particularly for the two million Americans diagnosed with skin cancer annually. By allowing patients to capture images from the comfort of their homes and upload them for review, 3Derm helps prioritize in-office appointments for those with more concerning conditions. The company's technology aims to transform teledermatology, offering a cost-effective solution that maintains the continuity of care with local dermatologists while ensuring high diagnostic quality. As of August 2020, 3Derm operates as a subsidiary of Digital Diagnostics, Inc.

Memory AS, a Norwegian startup based in Oslo, specializes in developing innovative tools aimed at enhancing productivity in the workplace. Established in 2013, the company is known for its flagship product, Timely, which is recognized as the world's first AI-powered time tracking and planning tool. In addition to Timely, Memory has launched Dewo, a personal assistant designed to facilitate deep work. By leveraging artificial general intelligence, Memory AS focuses on creating solutions that promote a better work-life integration and improve overall efficiency.

Integrity Implants focuses in developing unique expandable interbody technology. The company's goal is to make the lives of customers better through advances in minimally invasive procedures. Integrity Implants constructs innovative technologies and products that can contribute to the enhancement of patient and hospital outcomes as it pertains to orthopedics and spine. Integrity Implants was founded 2016 and is headquarters Jupiter, Florida.